Aspen starts local manufacture of anaesthetics at flagship Gqeberha site
Aspen's SVP2 Facility in Port Elizabeth
Aspen's SVP2 Facility in Port Elizabeth
Vials prior to filling at Aspen's SVP2 Facility in Port Elizabeth
Filled vials at Aspen's SVP2 Facility in Port Elizabeth
Trade, Industry and Competition Minister Ebrahim Patel has officially opened multinational specialty pharmaceutical company Aspen’s general anaesthetics production line at its flagship manufacturing site in Gqeberha.
This manufacturing capability will convert Aspen’s Gqeberha facility into one of the largest manufacturing hubs for general anaesthetic products in the world.
The unveiling of the general anaesthetics line follows shortly on the heels of a visit by President Cyril Ramaphosa earlier this year at the start of the production of the Johnson & Johnson Covid-19 vaccine.
Officiating at the opening of Aspen’s facility, Patel said the facility “consolidates the Eastern Cape as the most significant advanced pharmaceutical hub on the African continent and it will create local jobs”.
This is of particular importance, considering that, since the start of the Covid-19 pandemic, South Africa has experienced significant job losses, with small and the large businesses having faced closures and many having experienced revenue losses.
The start of operations is “timely” as anaesthetics are a class of drug that, among other uses, supports the treatment of Covid-19 patients who are on ventilators in intensive care units.
South Africa has, to date, imported the general anaesthetics needed in our healthcare system and the new production line will provide an important medical product for the local market, assuring security of supply, and the bulk of it will be exported across the world, contributing to global patient support.
Meanwhile, Aspen’s facility is able to produce up to 300-million Johnson & Johnson Covid-19 vaccine doses a year at full production. Should all raw materials be available, this figure will be ramped up to 415-million doses by February next year, which Patel cited as an “extraordinary achievement”.
Aspen intends to increase production further to 700-million doses by 2023.
In terms of international trade, however, Patel said the anaesthetic production line will allow South Africa to “bring something to the trading relationship”.
The anaesthetic lab time will immediately start generating business and will likely grow to more than R1.2-billion in yearly turnover by 2027.
Aspen group CEO Stephen Saad said the opening of the general anaesthetics manufacturing line is a “significant milestone” for Aspen as it will serve as a crucial anaesthetics hub for this critical medication.
“This is one of the world’s largest general anaesthetics production lines and it positively positions Aspen’s integrated supply, marketing, and sale of anaesthetics globally,” he commented.
Aspen has invested more than R3-billion in this facility, making it the “single largest investment in the pharmaceutical industry in the country” and aligns with Aspen’s commitment to supporting the industrialisation of South Africa.
Sterile Focus Brands, comprising anaesthetic and thrombosis products, is one of Aspen’s key business segments and contributes 28% of its revenue.
The general anaesthetics production line extends Aspen’s sterile footprint and complements the group’s strategic vision of delivering quality, affordable medicines using high-technology pharmaceutical equipment, contributing to improved health outcomes for patients.
Comments
Press Office
Announcements
What's On
Subscribe to improve your user experience...
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation